New York, NY · Founded 2020 · Privately Held (backing)
Developer of clinical-stage drugs designed for the treatment of autoimmune, cancer, and other serious diseases. Graviton BioScience is based in New York, NY and was founded in 2020. It was valued at $264 million at its early-stage round in Feb 2024, the last priced event on record. It has raised $93.3 million across 4 recorded rounds; the latest was a $25 million early-stage round in Jan 2024.
PMV mark · valuation
$264.0M
Oct 2026
Priced at
its early-stage round
Feb 2024
Total raised
$93.3M
Last round
Early Stage VC
Jan 2024
Cap table — not yet on record
Graviton BioScience's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Graviton BioScience with a free account
·Watch Graviton BioScience: the Monday email on marks, rounds and moves
Where does Graviton BioScience's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Graviton BioScience's 4 recorded funding rounds.
